Pending

A Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Active Ankylosing Spondylitis
Phase II Study of Hemay005 in Patients With Active Ankylosing Spondylitis
A Two-Part 26-Week Study of Etoricoxib as Treatment for Ankylosing Spondylitis (AS) (MK-0663-108)
Evaluate the Preliminary Efficacy, Safety, and PK of Subcutaneous JS005 in Chinese Adult Patients With Active AS
Terbinafine Treatment of Axial Spondyloarthropathy
Occurrence of Possible Rheumatologic Immune-Related Adverse Events (rh-irAEs) Associated with Immune Checkpoint Inhibitor (ICI) Therapy
Safety of anti-TNF agents in pregnancy
The ASAS-OMERACT core domain set for axial spondyloarthritis
Effects of fibromyalgia on the disease activity and treatment of patients with axial spondyloarthritis
Residual Pain in the Context of Selecting and Switching Biologic Therapy in Inflammatory Rheumatic Diseases
A cross-sectional study on clinical characteristics of Saudi axial spondylarthritis: preliminary results
Secukinumab in non-radiographic axial spondyloarthritis: subgroup analysis based on key baseline characteristics from a randomized phase III study, PREVENT
Assessment of Neuropathic Pain in Ankylosing Spondylitis: Prevalence and Characteristics
Secukinumab in axial spondyloarthritis: a narrative review of clinical evidence
Reply: comment on: Risk of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis initiating interleukin 17 inhibitors
Impact of obesity on quality of life, psychological status, and disease activity in psoriatic arthritis: a multi‑center study
Genetics, Epigenetics, and Gender Impact in Axial-Spondyloarthritis Susceptibility: An Update on Genetic Polymorphisms and Their Sex Related Associations
Awake fiberoptic intubation and use of bronchial blockers in ankylosing spondylitis patients
Reply to Niv Ben-Shabat: Mortality in AS according to treatment
Reply to letter
Axial spondyloarthritis: Emerging drug targets
Unstable Bony Chance Fracture Successfully Treated With Teriparatide in Patient With Ankylosed Spine: A Case Report and Review of the Literature
A comparative study of total knee arthroplasty outcome for stiff knee with or without sequential antirheumatic drug treatment
Mediterranean diet in axial spondyloarthritis: an observational study in an Italian monocentric cohort
Association of the Risk of Childhood Asthma at Age 6 With Maternal Allergic or Immune-Mediated Inflammatory Diseases: A Nationwide Population-Based Study
Ixekizumab: an IL-17A inhibitor for the treatment for the treatment of axial spondylarthritis
Long noncoding RNA intersectin 1-2 gradually declines during adalimumab treatment, and its reduction correlates with treatment efficacy in patients with ankylosing spondylitis
Ankylosing Spondylitis
Health-Related Quality of Life in Psoriatic Arthritis: Findings and Implications
Challenges during bilateral total temporomandibular joint replacement for ankylosis in ankylosing spondylitis patient-a case report
Congenital toxoplasmosis after adalimumab treatment before pregnancy
Metagenomic analysis revealed the potential role of gut microbiome in gout
Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management
Altered kynurenine pathway metabolism in patients with ankylosing spondylitis
Immunogenicity of subcutaneous TNF inhibitors and its clinical significance in real-life setting in patients with spondyloarthritis
Infliximab Treatment Does Not Lead to Full TNF-alpha Inhibition: A Target-Mediated Drug Disposition Model
Impact of filgotinib on sacroiliac joint MRI structural lesions at 12 weeks in patients with active ankylosing spondylitis (TORTUGA trial)
Underweight and obesity are strong predictors of clinical outcomes in patients with ankylosing spondylitis: data from the Smart-phone SpondyloArthritis Management System
Risk factors for diagnosis of psoriatic arthritis, psoriasis, rheumatoid arthritis, and ankylosing spondylitis: A set of parallel case-control studies
Persistence to Biologic Therapy among Patients with Spondyloarthritis: An Observational Study using the OPAL Dataset
Bioinformatics Analysis of the Molecular Mechanism and Potential Treatment Target of Ankylosing Spondylitis
Predicting Biologic Therapy Outcome of Patients With Spondyloarthritis: Joint Models for Longitudinal and Survival Analysis
Relation of therapies for ankylosing spondylitis and psoriatic arthritis to risk of myocardial infarction: a nested case control study
Investigating diagnosis, treatment, and burden of disease in patients with ankylosing spondylitis in Central Eastern Europe and the United States: a real-world study
Pain Medication and Corticosteroid Use in Ankylosing Spondylitis, Psoriatic Arthritis, and Rheumatoid Arthritis in the United States: A Retrospective Observational Study
Heart Involvement in a Moroccan Population with Spondyloarthritis: A Cross-sectional Study
Gastroenterological safety of IL-17 inhibitors: a systematic literature review
An update on the pathogenic role of IL-6 in rheumatic diseases
Disease Differentiation and Monitoring of Anti-TNF Treatment in Rheumatoid Arthritis and Spondyloarthropathies
HLA Allele Prevalence in Disease-Modifying Antirheumatic Drugs-Responsive Enthesitis and/or Arthritis Not Fulfilling ASAS Criteria: Comparison with Psoriatic and Undifferentiated Spondyloarthritis
Remission in axial spondyloarthritis: Developing a consensus definition
Changes in the use patterns of bDMARDs in patients with rheumatic diseases over the past 13 years
ATF6 aggravates angiogenesis-osteogenesis coupling during ankylosing spondylitis by mediating FGF2 expression in chondrocytes
The combined prevalence of classified rare rheumatic diseases is almost double that of ankylosing spondylitis
From Science to Success? Targeting Tyrosine Kinase 2 in Spondyloarthritis and Related Chronic Inflammatory Diseases
Tumor Necrosis Factor Inhibitors
Infliximab-abda
Secukinumab
Cost-Effectiveness of Therapeutic Drug Monitoring-Guided Adalimumab Therapy in Rheumatic Diseases: A Prospective, Pragmatic Trial
Targeted and biological drugs in the treatment of inflammatory rheumatic diseases
Randomized Cross Over Study Assessing the Efficacy of Non-invasive Stimulation of the Vagus Nerve in Patients With Axial Spondyloarthritis Resistant to Biotherapies: The ESNV-SPA Study Protocol
Microbiota-miRNA interactions: Opportunities in ankylosing spondylitis
Determination of serum methylarginine levels by tandem mass spectrometric method in patients with ankylosing spondylitis
Bridging the Gap between Symptom Onset and Diagnosis in Axial Spondyloarthritis
Factors associated with changes in volumetric bone mineral density and cortical area in men with ankylosing spondylitis: a 5-year prospective study using HRpQCT
Evaluating Chinese Mobile Health Apps for Ankylosing Spondylitis Management: Systematic App Search
Incomplete small bowel obstruction in a patient with ankylosing spondylitis
Multi-target mechanism of Tripteryguim wilfordii Hook for treatment of ankylosing spondylitis based on network pharmacology and molecular docking
Biological DMARDs and disease modification in axial spondyloarthritis: a review through the lens of causal inference
A Study of the Efficacy and Safety of Adalimumab in Pediatric Subjects With Enthesitis Related Arthritis
Infliximab Biosimilar CT-P13 Observational Studies for Rheumatoid Arthritis, Inflammatory Bowel Diseases, and Ankylosing Spondylitis: Pooled Analysis of Long-Term Safety and Effectiveness
Posterior wedge osteotomy assisted by O-arm navigation for treating ankylosing spondylitis with thoracolumbar fractures: an early clinical evaluation
Risk of thromboembolic events and associated risk factors, including treatments, in patients with immune-mediated diseases
Immune-mediated necrotising myopathy after treatment with adalimumab in a patient with HLA-B27 ankylosing spondylitis
Yanghe Decoction Suppresses the Experimental Autoimmune Thyroiditis in Rats by Improving NLRP3 Inflammasome and Immune Dysregulation
Effects of a 6-month exercise programme on disease activity, physical and functional parameters in patients with ankylosing spondylitis: Randomised controlled trial
SARS-CoV-2 Infection in Spondyloarthritis Patients Treated With Biotechnological Drugs: A Study on Serology
Trends in hospitalizations for vertebral compression fracture in ankylosing spondylitis: data from the National Inpatient Sample 2000-2014
Medication adherence and persistence of psoriatic arthritis patients treated with biological therapy in a specialty pharmacy in Brazil: a prospective observational study
Comparison of Retention Rates Between Tumor Necrosis Factor-alpha Inhibitors in Patients With Ankylosing Spondylitis: Data From the Korean College of Rheumatology Biologics Registry
A Study of CC-99677 in Participants With Active Ankylosing Spondylitis
The Value of Serum Amyloid A in the Diagnosis and Management of Ankylosing Spondylitis
Unexpected impact of COVID-19 lockdown on spinal mobility and health perception in spondyloarthritis
Response to: ‘Correspondence on ‘Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial” by Cai and Peng
Early monitoring of infliximab serum trough levels predicts long-term therapy failure in patients with axial spondyloarthritis
IL-33 Gene Polymorphisms as Potential Biomarkers of Disease Susceptibility and Response to TNF Inhibitors in Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Patients
Analysis of Bone Strength and Bone Turnover Markers in Ankylosing Spondylitis with Radiological Hip Involvement
Treat-to-target in axial spondyloarthritis: an observational study in daily practice
Secukinumab for the treatment of psoriasis, psoriatic arthritis, and axial spondyloarthritis: Physical and pharmacological properties underlie the observed clinical efficacy and safety
Response to: ‘Correspondence on ‘Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis: 16-week results from a randomised, placebo-controlled, phase 3 trial” by Zhao and Huang
Etanercept in the treatment of ankylosing spondylitis and nephrotic syndrome in the context of AA amyloidosis: A 48-month follow-up
Safety and Tolerability of AIN457 in Adults (18-65 Years) With Moderate to Severe Ankylosing Spondylitis
Effectiveness and safety of Chinese herbal formula combined with western medicine for ankylosing spondylitis: A protocol for systematic review and meta-analysis
The Salivary Microbiota, Cytokines, and Metabolome in Patients with Ankylosing Spondylitis Are Altered and More Proinflammatory than Those in Healthy Controls
Ultrasound Doppler enthesitis shows sensitivity to change after biological therapy in spondyloarthritis and psoriatic arthritis patients
Clinical Trials Supporting the Role of the IL-17/IL-23 Axis in Axial Spondyloarthritis
What is the optimal target for a T2T approach in axial spondyloarthritis?
Vagal Nerve Stimulation-Modulation of the Anti-Inflammatory Response and Clinical Outcome in Psoriatic Arthritis or Ankylosing Spondylitis
Relapse of ankylosing spondylitis and its predictors after withdrawal of tumor necrosis factor-alpha inhibitors: a 52-week follow-up study
Anterior uveitis in patients with spondyloarthritis treated with secukinumab or tumour necrosis factor inhibitors in routine care: does the choice of biological therapy matter?

Alloplastic Temporomandibular Joint Replacement in Patients With Systemic Inflammatory Arthritis and Connective Tissue Disorders
Cervical spine fracture-dislocation in patients with ankylosing spondylitis and severe thoracic kyphosis: Application of halo vest before and during surgical management
An innovative adjustable prone positioning frame for treatment of severe kyphosis secondary to ankylosing spondylitis with two-level osteotomy
HLA-B27 is associated with reduced disease activity in axial spondyloarthritis
Safety and Efficacy of Faecal Microbiota Transplantation in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory Diseases
Site-specific resolution of enthesitis in patients with axial spondyloarthritis treated with tumor necrosis factor inhibitors
Apremilast monotherapy for long-term treatment of active psoriatic arthritis in DMARD-naive patients
Influence of anti-TNF-alpha treatment on liver and kidney functions in patients with ankylosing spondylitis: A retrospective longitudinal study
Juvenile spondyloartropathies
Selective estrogen receptor modulator lasofoxifene suppresses spondyloarthritis manifestation and affects characteristics of gut microbiota in zymosan-induced SKG mice
SWE and SMI ultrasound techniques for monitoring needling treatment of ankylosing spondylitis: study protocol for a single-blinded randomized controlled trial
Use of telemedicine during the COVID-19 pandemic in patients with inflammatory arthritis: a retrospective study on feasibility and impact on patient-reported outcomes in a real-life setting
Echotexture Analysis of L4 Supraspinous Enthesis in Ankylosing Spondylitis
A case report of a boy suffering from type 1 diabetes mellitus and familial Mediterranean fever
Effectiveness of self-management interventions in inflammatory arthritis: a systematic review informing the 2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis
Clinical factors associated with discontinuation of ts/bDMARDs in rheumatic patients from the BIOBADASER III registry
Clinical characteristics, disease activity, functional status, and quality of life results of patients with psoriatic arthritis using biological and conventional synthetic disease-modifying antirheumatic drugs
Infliximab therapy provides beneficial effects for choroidal thickness increase in patients with active ankylosing spondylitis: A possible mechanism mediating the suppressing of uveitis attacks
The Role of Sacroiliac Joint Steroid Injections in the Treatment of Axial Spondyloarthritis
Anti-tumor necrosis factor treatment in ankylosing spondylitis may not relate to poor prognosis in COVID-19
Nocebo effects of Janus kinase inhibitors in the treatment of active ankylosing spondylitis
Adalimumab
Circulating mature granzyme B+ T cells distinguish Crohn’s disease-associated axial spondyloarthritis from axial spondyloarthritis and Crohn’s disease
Systemic Sarcoidosis Reactions as a Result of Tumour Necrosis Alpha Treatment for Patients with Psoriasis
Effects of traditional qigong exercise on ankylosing spondylitis: a protocol for systematic reviews and meta-analysis
Janus kinase-signal transducers and activators of transcription cell signaling in Spondyloarthritis: rationale and evidence for JAK inhibition
Efficacy of warming needle moxibustion in the treatment of ankylosing spondylitis: A protocol of a randomized controlled trial
Percutaneous, PMMA-augmented, pedicle screw instrumentation of thoracolumbar ankylotic spine fractures
Comparative efficacy and safety of secukinumab 75 mg, 150 mg, and 300 mg in patients with active ankylosing spondylitis
Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry’
Successful Treatment of AA Amyloidosis in Ankylosing Spondylitis Using Tocilizumab: Report of Two Cases and Review of the Literature
Diagnostic delay is common for patients with axial spondyloarthritis: results from the National Early Inflammatory Arthritis Audit
Takayasu’s arteritis occurring under TNF blockers in a patient with spondyloarthritis: is it an association or a paradoxical effect?
Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis
Efficacy and safety of ultrasound-guided percutaneous nephrolithotomy for kidney calculi patients with ankylosing spondylitis: a retrospective single center analysis
Mortality in Ankylosing Spondylitis According to Treatment: A Nationwide Retrospective Cohort Study of 5900 Patients from Israel
2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis
Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial
Continuing versus withdrawing ixekizumab treatment in patients with axial spondyloarthritis who achieved remission: efficacy and safety results from a placebo-controlled, randomised withdrawal study (COAST-Y)
Evaluation of the Optimal Concentration Range of Adalimumab for Ankylosing Spondylitis in a Prospective Observational Cohort Study
Correction to: Rebuttal letter on “Comment on tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis-time to reconsider treatment guidelines? A case series and review of literature”
JAK1 selective inhibitors for the treatment of spondyloarthropathies
Efficacy of home-based physical activity interventions in patients with autoimmune rheumatic diseases: A systematic review and meta-analysis
microRNA-214-3p Suppresses Ankylosing Spondylitis Fibroblast Osteogenesis via BMP-TGFbeta Axis and BMP2
Uveitis in Patients with Ankylosing Spondylitis
The Prognostic Value of Pain Phenotyping in Relation to Treatment Outcomes in Patients with Axial Spondyloarthritis Treated in Clinical Practice: A Prospective Cohort Study
Value-Based Healthcare in Rheumatology: Axial Spondyloarthritis and Beyond
JAK Inhibitors for Axial Spondyloarthritis: What does the Future Hold?
Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study
Neurologically Asymptomatic Lumbar Traumatic Dislocation With Vascular Compression in a Patient With Ankylosing Spondylitis: Case Report
Rheumatic manifestations of Chikungunya virus infection: Prevalence, patterns, and enthesitis
Nanomedicine Strategies for Anti-Inflammatory Treatment of Noninfectious Arthritis
Comparison of Men and Women With Axial Spondyloarthritis in the US-Based Corrona Psoriatic Arthritis/Spondyloarthritis Registry
Genetic hypothesis involving Haglund’s syndrome and its association with ankylosing spondylitis: case report
Rheumatoid arthritis coexisting with ankylosing spondylitis: A report of 22 cases with delayed diagnosis
The efficacy of moxibustion and acupuncture therapy for ankylosing spondylitis: A protocol for an overview of systematic reviews and meta-analysis
Dynamic Thiol/Disulphide Homeostasis as Oxidative Stress Marker in Ankylosing Spondylitis and Undifferentiated Spondyloarthropathy
Efficacy and Safety of SHR-1314 in Patients With Active Ankylosing Spondylitis
Staged two level non-contiguous vertebral column resection: technique and case report
COVID-19 Vaccination in Rheumatic Disease Patients
Risk factors for losing hepatitis B virus surface antibody in patients with HBV surface antigen negative/surface antibody positive serostatus receiving biologic disease-modifying anti-rheumatic drugs: a nested case-control study
The risk of malignancy in secukinumab-treated psoriasis, psoriatic arthritis and ankylosing spondylitis patients: analysis of up to five-year clinical trial and post-marketing surveillance data
MALT-1 inhibition attenuates the inflammatory response of ankylosing spondylitis by targeting NF-kappaB activation
Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis: 16-week results from a randomised, placebo-controlled, phase 3 trial
Real-world experiences of the diagnosis process in Korean patients with ankylosing spondylitis based on a self-report questionnaire
Do patients with rheumatoid arthritis show a different course of COVID-19 compared to patients with spondyloarthritis?
Sustained clinical response and safety of etanercept in patients with early axial spondyloarthritis: 10-year results of the ESTHER trial
Ankylosing spondylitis rehabilitation publications and the global productivity: a Web of Science-based bibliometric analysis (2000-2019)
Effectiveness and persistence of golimumab as a second biological drug in patients with spondyloarthritis: A retrospective study
Single-cell analysis reveals innate immunity dynamics in ankylosing spondylitis
Spurious Uptake on 68Ga-Prostate-Specific Membrane Antigen PET/CT Due to Ankylosing Spondylitis; A Rare Pitfall in Imaging of Biochemical Recurrence of Prostate Cancer
Nonpharmacologic Pain Management in Inflammatory Arthritis
Differences in multi-segmental spine kinematics between patients with different stages of axial spondyloarthritis and healthy controls
Patients With Ankylosing Spondylitis Are Associated With High Risk of Fibromyalgia: A Nationwide Population-Based Cohort Study
Choroidal Thickness Is a Biomarker Associated With Response to Treatment in Ankylosing Spondylitis
Surgical Treatment for Cervical Spine Fracture in Patients With Ankylosing Spondylitis: Single Posterior Approach or Combined Anterior-posterior Approach?
Efficacy and safety of interleukin-17 inhibitors in the treatment of chronic rheumatic diseases: A combined and updated meta-analysis
miRNAs as potential biomarkers of treatment outcome in rheumatoid arthritis and ankylosing spondylitis
Glomerulonephritis in Two Patients with SpA Treated with TNF-α Blockers and a Review of the Literature
Synchronous or sequential cementless bilateral total hip arthroplasty for osseous ankylosed hips with ankylosing spondylitis
Rx IALTA: evaluating the effect of a pharmacist-led intervention on CV risk in patients with chronic inflammatory diseases in a community pharmacy setting: a prospective pre-post intervention study
Anti- and non-tumor necrosis factor-alpha-targeted therapies effects on insulin resistance in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
Self-Reported Medication Adherence in Patients With Ankylosing Spondylitis: The Role of Illness Perception and Medication Beliefs
Myelin oligodendrocyte glycoprotein antibody-associated disorders coexisting with ankylosing spondylitis: Potential association between demyelination and tumor necrosis factor inhibitors
Naproxen
Is family history a predictor of response to tumour necrosis factor inhibitors in spondyloarthritis? A Swedish nationwide cohort study
Ankylosing spondylitis risk factors: a systematic literature review
Rebuttal letter on “Comment on Tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis-time to reconsider treatment guidelines? A case series and review of literature”
Comment on “Tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis-time to reconsider treatment guidelines? A case series and review of literature”
Perspectives on the Genetic Associations of Ankylosing Spondylitis
Chondrogenesis mediates progression of ankylosing spondylitis through heterotopic ossification
Dysphagia in a patient with ankylosing spondylitis: A case report
Effectiveness and safety of anti-TNF therapy for ankylosing spondylitis: a real-word study
Biomechanical influence of the surgical approaches, implant length and density in stabilizing ankylosing spondylitis cervical spine fracture
Clonorchis sinensis-Derived Protein Attenuates Inflammation and New Bone Formation in Ankylosing Spondylitis
ABY-035 in the Treatment of Subjects With Ankylosing Spondylitis
The influence of the SARS-CoV-2 lockdown on patients with inflammatory rheumatic diseases on their adherence to immunomodulatory medication – a cross sectional study over 3 months in Germany
Association of homocysteine with ankylosing spondylitis: a systematic review and meta-analysis
Top 100 cited articles on ankylosing spondylitis
IL-23 Inhibition in Ankylosing Spondylitis: Where Did It Go Wrong?

From the Genetics of Ankylosing Spondylitis to New Biology and Drug Target Discovery
Serum Metabolomics Signatures Associated With Ankylosing Spondylitis and TNF Inhibitor Therapy
Circulating miR-145 as a marker of therapeutic response to anti-TNF therapy in patients with ankylosing spondylitis
Secukinumab as a potential trigger of inflammatory bowel disease in ankylosing spondylitis or psoriatic arthritis patients
A Mimic of Ankylosing Spondylitis, Ochronosis: Case Report and Review of the Literature
Use of conventional synthetic and biologic disease-modifying anti-rheumatic drugs in patients with rheumatic diseases contracting COVID-19: a single-center experience
Serum golimumab concentration and anti-drug antibodies are associated with treatment response and drug survival in patients with inflammatory joint diseases: data from the NOR-DMARD study
The efficacy of manual soft-tissue mobilization in ankylosing spondylitis: A randomized controlled study
Is the impact of biologic agents in enteropathic spondylitis different from other spondylitis? Real life data from the HUR-BIO Registry
Novel approaches to develop biomarkers predicting treatment responses to TNF-blockers
The relationship of ischemia-modified albumin levels to disease activity scores and HLA-B27 in patients with ankylosing spondylitis
Quality of life and therapeutic management of axial spondyloarthritis patients in Italy: a 12-month prospective observational study
Efficacy and safety of warm acupuncture in the treatment of ankylosing spondylitis: A protocol for systematic review and meta-analysis
Factors Associated With Major Complications and Mortality During Hospitalization in Patients With Ankylosing Spondylitis Undergoing Surgical Management for a Spine Fracture
Assessment of Treatment Safety and Quality of Life in Patients Receiving Etanercept Biosimilar for Autoimmune Arthritis (ASQA): A Multicenter Post-marketing Surveillance Study
Successful use of tofacitinib in the treatment of diffuse systemic sclerosis and axial spondyloarthritis: a case-based review
Persistence of secukinumab in patients with psoriasis, psoriatic arthritis, and ankylosing spondylitis
GlutenSpA trial: protocol for a randomised double-blind placebo-controlled trial of the impact of a gluten-free diet on quality of life in patients with axial spondyloarthritis
Jacques Forestier: Forgotten Contributions of a Rheumatologist to Spine Surgery
The Delay of Diagnosis in Spondyloarthropathy Patients in a Tertiary Hospital in Saudi Arabia
Relation of NSAID, DMARD and TNF-inhibitors for Ankylosing Spondylitis and Psoriatic Arthritis to Risk of Total Hip and Knee Arthroplasty
The role of lymphocyte-monocyte ratio on axial spondyloarthritis diagnosis and sacroiliitis staging
Biomarkers of Cardiovascular Disease in Patients With Ankylosing Spondylitis
Concomitant Diagnosis of Fibromyalgia and Ankylosing Spondylitis: Relation to Clinical Features and Plasma Pentraxin -3 Level
Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study
Pregnancy outcomes in women with ankylosing spondylitis: a scoping literature and methodological review
Brazilian recommendations for the use of nonsteroidal anti-inflammatory drugs in patients with axial spondyloarthritis
Safety of secukinumab for the treatment of active ankylosing spondylitis
Efficacy and safety of thalidomide on psychological symptoms and sleep disturbances in the patient with refractory ankylosing spondylitis
Erectile Dysfunction, Testosterone Levels and Disease Activity in Ankylosing Spondylitis Patients
The role of ixekizumab in non-radiographic axial spondyloarthritis
TLR expression profiles are a function of disease status in rheumatoid arthritis and experimental arthritis
The risk factors and incidence of major infectious diseases in patients with ankylosing spondylitis receiving tumor necrosis factor inhibitors
Multidisciplinary team intervention to reduce the nocebo effect when switching from the originator infliximab to a biosimilar
Body Mass Index and Disease Activity in Chronic Inflammatory Rheumatic Diseases: Results of the Cardiovascular in Rheumatology (Carma) Project
Similar biologic drug response regardless of radiographic status in axial spondyloarthritis: data from the BSRBR-AS registry
Differences in biologics for treating ankylosing spondylitis: the contribution of network meta-analysis
Structural changes in the sacroiliac joint on MRI and relationship to ASDAS inactive disease in axial spondyloarthritis: a 2-year study comparing treatment with etanercept in EMBARK to a contemporary control cohort in DESIR
Onset of IgA nephropathy in a patient treated with infliximab for ankylosing spondylitis
Post-transplant manifestation of ankylosing spondylitis: a case report and review of literature
Low BASDAI score alone is not a good predictor of anti-tumor necrosis factor treatment efficacy in ankylosing spondylitis: a retrospective cohort study
A single center experience: Physician related diagnostic delay and demographic and clinical differences between patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis
To move or not to move: the paradoxical effect of physical exercise in axial spondyloarthritis
Concurrent chronic hyperplastic candidosis and oral lichenoid lesion as adverse events of secukinumab therapy
Magnetic resonance imaging in ankylosing spondylitis: reduction of active sacroiliitis and hip arthritis during treatment with an adalimumab biosimilar
Osteoimmunological insights into the pathogenesis of ankylosing spondylitis
Safety and Efficacy of Prefilled Liquid Etanercept-Biosimilar Yisaipu for Active Ankylosing Spondylitis: A Multi-Center Phase III Trial
Sarcopenia, immune-mediated rheumatic diseases, and nutritional interventions
Which patient-reported outcomes do rheumatology patients find important to track digitally? A real-world longitudinal study in ArthritisPower
Modulatory Impact of Adipose-Derived Mesenchymal Stem Cells of Ankylosing Spondylitis Patients on T Helper Cell Differentiation
TCM nonpharmacological interventions for ankylosing spondylitis: A protocol for systematic review and network meta-analysis
Suspecting and Diagnosing the Patient with Spondyloarthritis and What to Expect from Therapy
A phase III randomized study of apremilast, an oral phosphodiesterase 4 inhibitor, for active ankylosing spondylitis
Bisphosphonates in inflammatory rheumatic diseases
Effectiveness and safety of secukinumab in 608 patients with psoriatic arthritis in real life: a 24-month prospective, multicentre study
Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature Review
Comparing symptoms, treatment patterns, and quality of life of ankylosing spondylitis and non-radiographic axial spondyloarthritis patients in the USA: findings from a patient and rheumatologist Survey
Comment on: Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey.
Could anti-TNF treatment have affected HRV and HRT results?
Ovarian reserve in patients with ankylosing spondylitis.
The contribution of pre-existing spinal pseudarthrosis to the surgical correction for thoracolumbar kyphosis secondary to ankylosing spondylitis.
Sexual and mental health of woman suffering from selected connective tissue diseases: an original paper.
Comparing symptoms, treatment patterns, and quality of life of ankylosing spondylitis and non-radiographic axial spondyloarthritis patients in the USA: findings from a patient and rheumatologist Survey.
Effectiveness and safety of secukinumab in 608 patients with psoriatic arthritis in real life: a 24-month prospective, multicentre study.
Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature Review.
Drug-induced Sarcoid Uveitis with Biologics.
New onset of axial spondyloarthropathy in patients treated with isotretinoin for acne vulgaris: incidence, follow-up, and MRI findings.
Suspecting and Diagnosing the Patient with Spondyloarthritis and What to Expect from Therapy.
A phase III randomized study of apremilast, an oral phosphodiesterase 4 inhibitor, for active ankylosing spondylitis.
Bisphosphonates in inflammatory rheumatic diseases.
TCM nonpharmacological interventions for ankylosing spondylitis: A protocol for systematic review and network meta-analysis.
Modulatory Impact of Adipose-Derived Mesenchymal Stem Cells of Ankylosing Spondylitis Patients on T Helper Cell Differentiation.
Effect of biologic disease-modifying anti-rheumatic drugs targeting remission in axial spondyloarthritis: systematic review and meta-analysis.
Which patient-reported outcomes do rheumatology patients find important to track digitally? A real-world longitudinal study in ArthritisPower.
Sarcopenia, immune-mediated rheumatic diseases, and nutritional interventions.
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome.
Magnetic resonance imaging in ankylosing spondylitis: reduction of active sacroiliitis and hip arthritis during treatment with an adalimumab biosimilar.
Osteoimmunological insights into the pathogenesis of ankylosing spondylitis.
Safety and Efficacy of Prefilled Liquid Etanercept-Biosimilar Yisaipu for Active Ankylosing Spondylitis: A Multi-Center Phase III Trial.
[Vladimir Bekhterev – A Protagonist of Research on Hypnosis?]
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement.
To move or not to move: the paradoxical effect of physical exercise in axial spondyloarthritis.
Concurrent chronic hyperplastic candidosis and oral lichenoid lesion as adverse events of secukinumab therapy.
Pharmaco-utilization of biologic drugs in patients affected by psoriasis, psoriatic arthritis and ankylosing spondylitis in an Italian real-world setting.
Low BASDAI score alone is not a good predictor of anti-tumor necrosis factor treatment efficacy in ankylosing spondylitis: a retrospective cohort study.
A single center experience: Physician related diagnostic delay and demographic and clinical differences between patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis.
Relationship between sleep quality and physical activity level in patients with ankylosing spondylitis.
Study Of Celecoxib Or Diclofenac For Efficacy and Safety In Chinese Patients With Ankylosing Spondylitis
A Pilot Open-Label Crossover Bioavailability Study of Celecoxib in Healthy Volunteers
Post-transplant manifestation of ankylosing spondylitis: a case report and review of literature.
Structural changes in the sacroiliac joint on MRI and relationship to ASDAS inactive disease in axial spondyloarthritis: a 2-year study comparing treatment with etanercept in EMBARK to a contemporary control cohort in DESIR.
Onset of IgA nephropathy in a patient treated with infliximab for ankylosing spondylitis.
Crohn’s disease in patients treated with etanercept.
From observational studies to personalized treatment in spondylarthritis: focus on IL-17 inhibition.
Differences in biologics for treating ankylosing spondylitis: the contribution of network meta-analysis.
Body Mass Index and Disease Activity in Chronic Inflammatory Rheumatic Diseases: Results of the Cardiovascular in Rheumatology (Carma) Project.
Similar biologic drug response regardless of radiographic status in axial spondyloarthritis: data from the BSRBR-AS registry.
The Risk Factors and Incidence of Major Infectious Diseases in Patients with Ankylosing Spondylitis Receiving Tumor Necrosis Factor Inhibitors.
Multidisciplinary team intervention to reduce the nocebo effect when switching from the originator infliximab to a biosimilar.
Pentraxin 3: A promising therapeutic target for autoimmune diseases.

The role of ixekizumab in non-radiographic axial spondyloarthritis.
TLR expression profiles are a function of disease status in rheumatoid arthritis and experimental arthritis.
The effect of reducing systemic inflammation on serum urate.
Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort.
Differential Diagnosis of Facet Joint Disorders.
Efficacy and safety of thalidomide on psychological symptoms and sleep disturbances in the patient with refractory ankylosing spondylitis.
The relationship between erectile dysfunction and testosterone level, disease activity and quality of life in ankylosing spondylitis.
Brazilian recommendations for the use of nonsteroidal anti-inflammatory drugs in patients with axial spondyloarthritis.
Safety of secukinumab for the treatment of active ankylosing spondylitis.
Pregnancy outcomes in women with ankylosing spondylitis: a scoping literature and methodological review.
Biomarkers of Cardiovascular Disease in Patients With Ankylosing Spondylitis.
Concomitant Diagnosis of Fibromyalgia and Ankylosing Spondylitis: Relation to Clinical Features and Plasma Pentraxin -3 Level.
The role of lymphocyte-monocyte ratio on axial spondyloarthritis diagnosis and sacroiliitis staging.
Relation of NSAID, DMARD and TNF-inhibitors for Ankylosing Spondylitis and Psoriatic Arthritis to Risk of Total Hip and Knee Arthroplasty.
The Delay of Diagnosis in Spondyloarthropathy Patients in a Tertiary Hospital in Saudi Arabia.
Switching and Discontinuation Patterns Among Patients Stable on Originator Infliximab Who Switched to an Infliximab Biosimilar or Remained on Originator Infliximab.
Persistence of secukinumab in patients with psoriasis, psoriatic arthritis, and ankylosing spondylitis.
GlutenSpA trial: protocol for a randomised double-blind placebo-controlled trial of the impact of a gluten-free diet on quality of life in patients with axial spondyloarthritis.
Jacques Forestier: Forgotten Contributions of a Rheumatologist to Spine Surgery.
Percutaneous Nephrolithotomy under Local Infiltration Anesthesia in Kneeling Prone Position for a Patient with Spinal Deformity.
Efficacy and safety of warm acupuncture in the treatment of ankylosing spondylitis: A protocol for systematic review and meta-analysis.
Factors Associated With Major Complications and Mortality During Hospitalization in Patients With Ankylosing Spondylitis Undergoing Surgical Management for a Spine Fracture.
Assessment of Treatment Safety and Quality of Life in Patients Receiving Etanercept Biosimilar for Autoimmune Arthritis (ASQA): A Multicenter Post-marketing Surveillance Study.
Successful use of tofacitinib in the treatment of diffuse systemic sclerosis and axial spondyloarthritis: a case-based review.
The direct and indirect costs of axial spondyloarthritis (axSpA) in Singapore.
Measuring bone density in axial spondyloarthropathy: Time to turn things on their side?
Quality of life and therapeutic management of axial spondyloarthritis patients in Italy: a 12-month prospective observational study.
Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis.
The impact of autoimmune systemic inflammation and associated medications on male reproductive health in patients with chronic rheumatological, dermatological, and gastroenterological diseases: A systematic review.
Dose Reduction of Tumor Necrosis Factor Inhibitor and its Effect on Medical Costs for Patients with Ankylosing Spondylitis.
A pilot study of a nurse-led integrated care review (the INCLUDE review) for people with inflammatory rheumatological conditions in primary care: feasibility study findings.
Blockade of translationally controlled tumor protein attenuated the aggressiveness of fibroblast-like synoviocytes and ameliorated collagen-induced arthritis.
Increased proportion of comorbidities but no deterioration of sexual QOL during a 5-year follow-up in patients with axSpA in the biologic treatment era.
Minimally Invasive versus Conventional Open Surgery for Fixation of Spinal Fracture in Ankylosed Spine.
A retrospective review of the adverse effects of biological therapy and reasons for its discontinuation in a resource-limited setting.
Axial spondyloarthritis: new advances in diagnosis and management.
B7-H3: A promising therapeutic target for autoimmune diseases.
Interferon-related gene expression in response to TNF inhibitor treatment in ankylosing spondylitis patients: a pilot study.
First Biologic Drug Persistence in Patients With Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: A Real-World Canadian Physicians’ Experience.
Tripterygium wilfordii Hook F. in the treatment of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a clinical trial.
Impact of tumor necrosis factor α inhibitors on MRI inflammation in axial spondyloarthritis assessed by Spondyloarthritis Research Consortium Canada score: A meta-analysis.
Physical Therapists’ Ability to Distinguish Between Inflammatory and Noninflammatory Arthritis and to Appropriately Refer Patients to a Rheumatologist.
Effects of sulfasalazine combined with moxibustion methods on patients with cold-dampness obstruction type ankylosing spondylitis.
Axial spondyloarthritis: concept, construct, classification and implications for therapy.
Predicting functional disability in patients with spondyloarthritis using a CRP-based algorithm: A 3-year prospective study.
Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): Evolving concept of CT findings, pathology and management.
Changes in Efficacy Indicators for Adalimumab Biosimilar Candidate (HS016) for the Treatment of Active Ankylosing Spondylitis at Various Time Points.
Spinal fractures in patients with ankylosing spondylitis: A case report and literature review.
Golimumab (anti-TNF monoclonal antibody): where we stand today.
Comorbidity and response to TNF inhibitors in axial spondyloarthritis: longitudinal analysis of the BSRBR-AS.
Effect of Music Therapy Intervention on Physical Functions and Mental Health of Patients with Ankylosing Spondylitis.
SNP-adjacent super enhancer network mediates enhanced osteogenic differentiation of MSCs in ankylosing spondylitis.
Associations of Platelet Count with Inflammation and Response to Anti-TNF-α Therapy in Patients with Ankylosing Spondylitis.
Skin manifestations in spondyloarthritis.
Secondary Membranous Nephropathy. A Narrative Review.
Vaccine targeting TNF epitope 1-14 do not suppress host defense against Mycobacterium bovis Bacillus Calmette-Guérin infection.
Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial.
CD74 auto-antibodies display little clinical value in Chinese Han population with axial spondyloarthritis.
Cost of Illness, Quality of Life, and Work Outcomes in Active Ankylosing Spondylitis Patients Treated With Adalimumab in China.
Evolution in the Understanding of Pediatric Onset Axial Spondyloarthritis.
Cervical Flexion Osteotomy through One-Stage Posterior-Anterior-Posterior Approach for Cervical Extension Deformity in Ankylosing Spondylitis: A Novel Surgical Technique.
Soluble vascular biomarkers in rheumatoid arthritis and ankylosing spondylitis: effects of one-year anti-TNF-α therapy.
Secukinumab Demonstrates Sustained Efficacy and Safety in a Taiwanese Subpopulation With Active Ankylosing Spondylitis: Four-Year Results From a Phase 3 Study, MEASURE 1.
Research hotspots and trends analysis of ankylosing spondylitis: a bibliometric and scientometric analysis from 2009 to 2018.
Pulmonary Sarcoidosis Induced by Anti-Tumor Necrosis Factor Therapy: A Paradoxical Effect.
Association Between Enthesitis and Health-related Quality of Life in Psoriatic Arthritis in Biologic-naive Patients from 2 Phase III Ustekinumab Trials.
Cardiovascular Disease in Spondyloarthritides.
Nonsteroidal Antiinflammatory Drug Use and Association With Incident Hypertension in Ankylosing Spondylitis.
Advances in Microbiome Detection Technologies and Application in Antirheumatic Drug Design.
A systematic review of surgical procedures on thoracic myelopathy.
Autoantibodies against Protein Phosphatase Magnesium-Dependent 1A as a Biomarker for Predicting Radiographic Progression in Ankylosing Spondylitis Treated with Anti-Tumor Necrosis Factor Agents.
Efficacy and Safety of Intra-articular Sacroiliac Glucocorticoid Injections in Ankylosing Spondylitis.
Long-term effectiveness and safety of infliximab and golimumab in ankylosing spondylitis patients from a Canadian prospective observational registry.
Conventional disease-modifying antirheumatic drugs therapy may not slow spinal radiographic progression in ankylosing spondylitis: results from an 18-year longitudinal dataset.
Tuberculosis risk in patients with rheumatologic disease treated with biologic drugs.
Clinical Review Report: Ixekizumab (Taltz): (Eli Lilly Canada Inc.): Indication: For the treatment of adult patients with active ankylosing spondylitis who have responded inadequately to, or are intolerant to conventional therapy
Similarities and differences between non-radiographic and radiographic axial spondyloarthritis: The patient perspective from the Spanish atlas.
Double Glomerulonephritis in a Patient with Ankylosing Spondylitis Treated with Biologic Agent: Extrarticolar Involvement or Anti-Tumor Necrosis Factor Alpha Injury? A Case-Based Review.
The impact of extra-musculoskeletal manifestations on disease activity, functional status, and treatment patterns in patients with axial spondyloarthritis: results from a nationwide population-based study.
Is treatment in patients suspected of non-radiographic Axial Spondyloarthritis effective? Six months results of a placebo-controlled trial.
Children with enthesitis-related arthritis could benefit from treatments targeted for adults with spondyloarthritis.
Long-term effect of TNF Inhibitors on Radiographic Progression in Ankylosing Spondylitis is associated with time-averaged CRP Levels.
Impact of Secukinumab on Patient-Reported Outcomes in the Treatment of Ankylosing Spondylitis: Current Perspectives.
Immune response profiling of patients with spondyloarthritis reveals signalling networks mediating TNF-blocker function in vivo.
Adalimumab for Adult Patients with Rheumatological Disorders: A Review of Clinical Effectiveness
ERAP1 allotypes shape the epitope repertoire of virus-specific CD8+ T cell responses in acute hepatitis C virus infection.
Quality of internet videos related to exercise therapy of ankylosing spondylitis from mainland China : Content analysis.
The societal impact of a biologic treatment of ankylosing spondylitis: a case study based on secukinumab.
One-year treatment outcomes of secukinumab versus tumor necrosis factor inhibitors in Spondyloarthritis.
C7 extension crosswise osteotomy: a novel osteotomy for correction of chin-on-chest deformity in a patient with ankylosing spondylitis.
Therapeutic exercises and rehabilitation in axial spondyloarthropathy: Balancing benefits with unique challenges in the Asia-Pacific countries.
Axial spondyloarthritis and axial psoriatic arthritis: similar or different disease spectrum?
Pharmacoeconomic Review Report: Ixekizumab (Taltz): (Eli Lilly Canada Inc.): Indication: For the treatment of adult patients with active ankylosing spondylitis who have responded inadequately to, or are intolerant to conventional therapy
Chinese herbal medicine Yanghe decoction for ankylosing spondylitis: A protocol for systematic review and meta-analysis.
STAT3 Phosphorylation Inhibition for Treating Inflammation and New Bone Formation in Ankylosing Spondylitis.
Effects of types and degrees of ankylosing spondylitis hip structural damages on post-total hip arthroplasty outcome measurements.
Tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis-time to reconsider treatment guidelines? A case series and review of literature.
Depression in patients with spondyloarthritis: prevalence, incidence, risk factors, mechanisms and management.
Secukinumab Provides Sustained Reduction in Fatigue in Patients with Ankylosing Spondylitis: Long-term Results of Two Phase III Randomized Controlled Trials.
Effects of non-manipulative osteopathic management in addition to physical therapy and rehabilitation on clinical outcomes of ankylosing spondylitis patients: A preliminary randomized clinical trial.

Machine learning to predict early TNF inhibitor users in patients with ankylosing spondylitis.
Taiwan Rheumatology Association consensus recommendations for the management of axial spondyloarthritis.
Usefulness of CHA2 DS2 -VASc score to predict mortality and hospitalization in patients with inflammatory arthritis.
Relationship between characteristics of spinopelvic alignment and quality of life in Japanese patients with ankylosing spondylitis: a cross-sectional study.
Ankylosing spondylitis and psoriatic arthritis: revisiting screening of latent tuberculosis infection and its follow-up during anti-tumor necrosis factor therapy in an endemic area.
Clinical Associations of Uveitis in Axial Spondyloarthritis Group and Ankylosing Spondylitis Group: Do They Represent the Same Disease?
Therapeutic drug monitoring of infliximab compared to standard clinical treatment with infliximab: study protocol for a randomised, controlled, open, parallel-group, phase IV study (the NOR-DRUM study).
Add-On Effects of Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs in Ankylosing Spondylitis: Data from a Real-World Registered Study in China.
Activation of c-Jun N-Terminal Kinase, a Potential Therapeutic Target in Autoimmune Arthritis.
Concerns, healthcare use, and treatment interruptions in patients with common autoimmune rheumatic diseases during the COVID-19 pandemic.
Short-Term Efficacy and Safety of Secukinumab for Ankylosing Spondylitis: A Systematic Review and Meta-Analysis of RCTs.
Head-to-Head Comparison of Etanercept vs. Adalimumab in the Treatment of Ankylosing Spondylitis: An Open-Label Randomized Controlled Crossover Clinical Trial.
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature research.
Gene-regulatory network analysis of ankylosing spondylitis with a single-cell chromatin accessible assay.
The design of ibuprofen-loaded microbeads using polymers obtained from Xanthosoma sagittifolium and Dillenia indica.
Gout in the Chest Misdiagnosed as Ankylosing Spondylitis.
Immunogenicity of antitumor necrosis factor therapy in patients with spondyloarthritis.
Immune-mediated necrotizing myopathy after treatment with adalimumab in a patient with HLA-B27 ankylosing spondylitis.
Optimization of HLA-B*27 ALLELE Genotyping by PCR-SSP.
Ankylosing spondylitis and psoriatic arthritis: revisiting screening of latent tuberculosis infection and its follow-up during anti-tumor necrosis factor therapy in an endemic area.
Evaluation of the oral administration of α-l-guluronic acid on COX-1 and COX-2 gene expression profile in ankylosing spondylitis patients.
Response to Tumor Necrosis Factor-α Blocker in Patients With Ankylosing Spondylitis: Methodologic Issues for Clinical Outcome Prediction.
Reply to “Response to Tumor Necrosis Factor-α Blocker in Patients With Ankylosing Spondylitis: Methodologic Issues for Clinical Outcome Prediction”.
Surgical strategies in management of ankylosed bilateral hips and knees in crouched posture.
Role of secukinumab in ankylosing spondylitis with tubercular uveitis.
Fibrinogen-Like Protein 1 Is a Novel Biomarker for Predicting Disease Activity and Prognosis of Rheumatoid Arthritis.
“Mobile Health” for the Management of Spondyloarthritis and Its Application in China.
Clinical, Histopathological and Outcome Analysis of Five Patients With Lichenoid Eruption Following Anti-Tumor Necrosis Factor-Alpha Therapy for Ankylosing Spondylitis: Report of One Case and Review of the Literature.
Use of Robotic-Arm Assisted Technique in Complex Primary Total Hip Arthroplasty.
Surgical correction of rigid cervicothoracic deformity in a transgender patient: case report.
COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series.
A case of advanced ankylosing spondylitis complicated with cervical myelopathy due to ossification of yellow ligament in which bone histomorphometry demonstrated delayed calcification.
Cutaneous Vasculitis During Secukinumab Treatment.
NLRC4 inflammasomopathy with spondyloarthritis and a complete response to TNF inhibition.
Innate Lymphocytes in Inflammatory Arthritis.
Guselkumab improves joint pain in patients with pustulotic arthro-osteitis: A retrospective pilot study.
A Mechanism Underlying Sex-Associated Differences in Ankylosing Spondylitis: Troponin C2, Fast Skeletal Type (TNNC2) and Calcium Signaling Pathway.
Combination of methotrexate and sulfasalazine is an efficacious option for axial spondyloarthritis in a resource-limited, real-world clinical setting: a prospective cohort study.
Real-world evidence of the impact of adalimumab on work productivity and sleep measures in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
Evaluation of the impact of a nurse-led program of patient self-assessment and self-management in axial spondyloarthritis: results of a prospective, multicentre, randomized, controlled trial (COMEDSPA).
[Application of self-designed adjustable operation frame in treatment of severe kyphosis secondary to ankylosing spondylitis with posterior osteotomy].
Predictor of Surgical Outcomes in Ankylosing Spondylitis Cervical Spinal Fracture: An At Least 2 Years Follow-Up Retrospective Study.
The association between Candida infection and ankylosing spondylitis: a population-based matched cohort study.
Performance of Janus kinase inhibitors in psoriatic arthritis with axial involvement in indirect comparison with ankylosing spondylitis: a retrospective analysis from pooled data.
A Study of ARRY-371797 in Patients With Active Ankylosing Spondylitis
Comparison of the efficacy of physical examination and radiological imaging in detecting sacroiliitis in patients with juvenile spondyloarthropathies.
Potential regulatory factors in the pathogenesis of ankylosing spondylitis.
Health care utilization and cost associated with switching biologics within the first year of biologic treatment initiation among patients with ankylosing spondylitis.
Sex differences in brain modular organization in chronic pain.
Effects of Intravenous Golimumab on Health-Related Quality of Life in Patients with Ankylosing Spondylitis: 28-Week Results of the GO-ALIVE Trial.
Punicalagin Exerts Protective Effects against Ankylosing Spondylitis by Regulating NF-κB-TH17/JAK2/STAT3 Signaling and Oxidative Stress.
Understanding Barriers in the Pathway to Diagnosis of Ankylosing Spondylitis: Results From a US Survey of 1690 Physicians From 10 Specialties.
Early achievement of ASDAS clinical response is associated with long-term improvements in metrological outcomes in patients with ankylosing spondylitis treated with TNF-α blockers.
Correlations of fatigue in Danish patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis.
The Genetics of Spondyloarthritis.
National pharmacological treatment trends for ankylosing spondylitis in South Korea: A national health insurance database study.
Treat-to-target strategy with secukinumab as a first-line biological disease modifying anti-rheumatic drug compared to standard-of-care treatment in patients with active axial spondyloarthritis: protocol for a randomised open-label phase III study, AScalate.
Efficacy and safety of a single switch from etanercept originator to etanercept biosimilar in a cohort of inflammatory arthritis.
Association of Secukinumab Treatment With Tuberculosis Reactivation in Patients With Psoriasis, Psoriatic Arthritis, or Ankylosing Spondylitis.
Efficacy and Safety of Anti-Interleukin-17A Monoclonal Antibody Secukinumab in Treatment of Ankylosing Spondylitis: A Meta-Analysis.
Blocking IL-17: A Promising Strategy in the Treatment of Systemic Rheumatic Diseases.
Infliximab treatment reduces depressive symptoms in patients with ankylosing spondylitis: an ancillary study to a randomized controlled trial (ASSERT).
Prospective multicentre study of experience in real-world clinical practice in monitoring reported outcome measures (PROMs) of patient with a diagnosis of psoriatic and/or spondyloarthritis and initiating treatment with secukinumab.
Cost-Effectiveness of Treatment Strategies with Biologics in Accordance with Treatment Guidelines for Ankylosing Spondylitis: A Patient-Level Model.
Impact of cervical range of motion on the global spinal alignment in ankylosing spondylitis patients with thoracolumbar kyphosis following pedicle subtraction osteotomy.
Atorvastatin combined with low-dose dexamethasone for vascular endothelial cell dysfunction induced by chronic subdural hematoma.
Indomethacin can induce cell death in rat gastric parietal cells through alteration of some apoptosis- and autophagy-associated molecules.
Introduction and switching of biologic agents are associated with antidepressant and anxiolytic medication use: data on 42 815 real-world patients with inflammatory rheumatic disease.
Bimekizumab, a Novel Humanized IgG1 Antibody That Neutralizes Both IL-17A and IL-17F.
Reliability of an adapted core strength endurance test battery in individuals with axial spondylarthritis.
The Expression Levels of MicroRNAs Associated with T and B Cell Differentiation/stimulation in Ankylosing Spondylitis.
Metabolomic analysis of biochemical changes in the tissue and urine of proteoglycan-induced spondylitis in mice after treatment with moxibustion.
Micheliolide alleviates ankylosing spondylitis (AS) by suppressing the activation of the NLRP3 inflammasome and maintaining the balance of Th1/Th2 via regulating the NF-κB signaling pathway.
Increased Risk of Hypertension Associated with Spondyloarthritis Disease Duration: Results from the ASAS-COMOSPA Study.
Long-Term Safety of Adalimumab in 29,967 Adult Patients From Global Clinical Trials Across Multiple Indications: An Updated Analysis.
Interleukin-1β, interleukin-6, and interleukin-17A as indicators reflecting clinical response to celecoxib in ankylosing spondylitis patients.
Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration.
Adherence to biologic disease-modifying antirheumatic drugs in adult patients with rheumatic diseases.
Oxidative stress-mediated mitochondrial dysfunction facilitates mesenchymal stem cell senescence in ankylosing spondylitis.
Primary Hypoparathyroidism Mimicking Ankylosing Spondylitis in a Young Man with Fahr’s Syndrome: A Case Report.
Drug Survival of Biologics in Treating Ankylosing Spondylitis: A Systematic Review and Meta-analysis of Real-World Evidence.
National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD.
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment.
Phenotypes and Pathophysiology of Syndromic Hidradenitis Suppurativa: Different Faces of the Same Disease? A Systematic Review.
Correspondence on ‘Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort’ by Micheroli et al.
[Application of quadriceps snip in complex total knee arthroplasty].
Performance and Predictors of Minimal Disease Activity Response in Peripheral Spondyloarthritis Patients Treated With Adalimumab.
Evaluation of Mobile Apps Targeted at Patients With Spondyloarthritis for Disease Monitoring: Systematic App Search.
Evaluating upadacitinib for the treatment of rheumatoid arthritis.
Secukinumab provided significant and sustained improvement in the signs and symptoms of ankylosing spondylitis: results from the 52-week, Phase III China-centric study, MEASURE 5.
The effect of intravenous golimumab on health-related quality of life and work productivity in adult patients with active ankylosing spondylitis: results of the phase 3 GO-ALIVE trial.
Erosive costo-vertebral joint arthrits-an uncommon manifestation of ankylosing spondylitis.
The effect of secukinumab treatment on hematological parameters in ankylosing spondylitis and psoriatic arthritis.
The Role of the IL-23/IL-17 Pathway in the Pathogenesis of Spondyloarthritis.
Recommendation for the Management of Spondyloarthritis Patients in Kuwait.
Impact of tumor necrosis factor inhibitors and methotrexate on diabetes mellitus among patients with inflammatory arthritis.
Increased Induction Infliximab Clearance Predicts Early Antidrug Antibody Detection.
Relationship between common carotid distensibility/aortic stiffness and cardiac left ventricular morphology and function in a group of patients affected by chronic rheumatic diseases: an observational study.
Direct costs in patients with chronic inflammatory arthropathies on biological therapy: a real-world data study.
Patient-reported Disease Activity in an Axial Spondyloarthritis Cohort during the COVID-19 Pandemic.

Comorbidity management in spondyloarthritis.
Improvement of Sleep Quality in Patients with Ankylosing Spondylitis Kyphosis after Corrective Surgery.
Treatment of Juvenile Spondyloarthritis: Where We Stand.
Bone changes and curative effect of infliximab in patients with ankylosing spondylitis.
The usefulness and validity of English-language videos on YouTube as an educational resource for spondyloarthritis.
Ankylosing spondylitis complicating Turner syndrome: Two case reports and a literature review.
An Analysis of Patient and Fracture Characteristics and Clinical Outcomes in Patients With Hyperostotic Spine Fractures.
Chest roentgenography is complementary to interferon-gamma release assay in latent tuberculosis infection screening of rheumatic patients.
Outcome of Stock Total Joint Replacement With Fat Grafting in Adult Temporomandibular Joint Ankylosis Patients.
Elevated free secretory component in early rheumatoid arthritis and prior to arthritis development in patients at increased risk.
Inhibition of spinal bone formation in AS: 10 years after comparing adalimumab to OASIS.
Pharmacovigilance of Biopharmaceuticals in Rheumatic Diseases, Adverse Events, Evolution, and Perspective: An Overview.
Characteristics and outcome of a first acute myocardial infarction in patients with ankylosing spondylitis.
Kimura’s disease and ankylosing spondylitis: A case report.
A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juvenile Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
Extraluminal bronchial blocker placement using both nostrils for lung isolation in a patient with limited mouth opening: A CARE-compliant case report.
A Review of the Botany, Traditional Use, Phytochemistry, Analytical Methods, Pharmacological Effects, and Toxicity of Angelicae Pubescentis Radix.
Quantitative Proteomic Analyses To Reveal the Key Features of Proteins in New Onset Ankylosing Spondylitis Patients.
Uveitis occurrence in patients with ankylosing spondylitis according to the type of tumour necrosis factor inhibitor: a cohort study of 175 patients.
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons.
HLA-B27-related uveitis and seasonal variation-an Indian perspective.
Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis: is the reason to switch relevant?
Short to mid-term outcome of total hip arthroplasty with cementless implants in patients younger than 25 years old.
Impact of Ixekizumab on Work Productivity in Patients with Ankylosing Spondylitis: Results from the COAST-V and COAST-W Trials at 52 Weeks.
Temperament and Character Profiles of Ankylosing Spondylitis Patients Compared With Major Depression Patients and Healthy Controls.
Rheumatic diseases and COVID-19: a cohort of 17 patients under DMARDs. Response to: ‘Comment on: Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept. A report on a COVID-19 patient with psoriatic arthritis receiving ustekinumab’ by Messina et al.
Real-world observational study of biosimilars in inflammatory arthritis treatment: A systematic literature review.
Speckle tracking echocardiography as a new diagnostic tool for an assessment of cardiovascular disease in rheumatic patients.
Adersson lesion occurred in the lumbosacral segment of a young man: A case report and literature review.
Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of AS
COVID-19 Global Rheumatology Alliance Registry, anti-IL-6 therapy, shared decision-making and patient outcomes. Response to: ‘Correspondence on ‘Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry’ by Gianfrancesco et al. Compassionate use of tocilizumab in severe COVID-19 with hyperinflammation prior to advent of clinical trials – a real-world district general hospital experience’ by Khan et al, ‘Comment on ‘Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry’ by Gianfrancesco M et al’ by Andreica et al and ‘COVID-19 outcomes in patients with systemic autoimmune diseases treated with immunomodulatory drugs’ by Ansarin et al.
Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study.
Efficacy of alendronate for the treatment of ankylosing spondylitis: A protocol for systematic review and meta-analysis.
Use of biologic agents and risk of tuberculosis in Brazil, a tuberculosis high-burden country.
[Effects of sports physiotherapy on ankylosing spondylitis].
Serial locally applied water-filtered infrared a radiation in axial spondyloarthritis – a randomized controlled trial.
Post-approval Safety Surveillance Study of Golimumab in the Treatment of Rheumatic Disease Using a United States Healthcare Claims Database.
Abnormal subgenual anterior cingulate circuitry is unique to women but not men with chronic pain.
[Bone remodeling after total hip arthroplasty with anatomic medullary locking prosthesis and its long-term effectiveness].
The European Map of Axial Spondyloarthritis: Capturing the Patient Perspective-an Analysis of 2846 Patients Across 13 Countries.
Mesenchymal Stem Cells Anti-Inflammatory Activity in Rats: Proinflammatory Cytokines.
Infliximab induced chronic inflammatory demyelinating polyneuropathy: a case report.
The effect of paternal exposure to immunosuppressive drugs on sexual function, reproductive hormones, fertility, pregnancy and offspring outcomes: a systematic review.
Recognizing Axial Spondyloarthritis: A Guide for Primary Care.
The Valued Life Activities Scale (VLAs): linguistic validation, cultural adaptation and psychometric testing in people with rheumatic and musculoskeletal diseases in the UK.
We Got Your Back! Help Care Seeking and Caregiving in Mexican Indigenous Men With Ankylosing Spondylitis.
Ixekinumab for the treatment of ankylosing spondylitis.
Golimumab improves patient-reported outcomes in daily practice of inflammatory rheumatic diseases in Germany.
Frequency of peripheral diseases in Korean patients with ankylosing spondylitis and the effectiveness of adalimumab.
Paradoxical gastrointestinal effects of interleukin-17 blockers.
Work Disability in Axial Spondyloarthritis.
Lumbar bone erosion with anterior dural ectasia in ankylosing spondylitis: a case report.
Assessing the effect of interventions for axial spondyloarthritis according to the endorsed ASAS/OMERACT core outcome set: a meta-research study of trials included in Cochrane reviews.
Etanercept in the treatment of ankylosing spondylitis and nephrotic syndrome in the context of AA amyloidosis: A 48-month follow-up.
Recent advances in managing axial spondyloarthritis.
Paediatric infections in the first 3 years of life after maternal anti-TNF treatment during pregnancy.
[Experimental study of individualized 3D printing-guided template combined with thoracolumbar pedicle screw placement for the treatment of ankylosing spondylitis].
Effects of mannuronic acid (M2000) on gene expression profile of signal transducer and activator of transcription proteins (STATs) in rheumatoid arthritis patients.
The American College of Rheumatology Fibromyalgia Criteria Are Useful in the Evaluation of Fibromyalgia Symptoms in Patients With Ankylosing Spondylitis: A Cross-Sectional Study.
Novel Method for Removal of Broken Intramedullary Interlocking Nail with a Subtrochanteric Fracture: A Case Report.
[Is it possible to delegate medical services to qualified nurses specialized in rheumatology when evaluating patients with suspicion of ankylosing spondylitis?-Results of the PredAS study].
Retention Rate and Efficacy of the Biosimilar CT-P13 Versus Reference Infliximab in Patients with Ankylosing Spondylitis: A Propensity Score-Matched Analysis from the Korean College of Rheumatology Biologics Registry.
[Phosphoproteomic analysis of peripheral blood mononuclear cells of ankylosing spondylitis patients].
Treatment of Axial Spondyloarthritis: What Does the Future Hold?
Dosage reduction and discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: protocol for a pragmatic, randomised controlled trial (the BIOlogical Dose OPTimisation (BIODOPT) trial).
[Physical factors in the treatment of patients with spondylarthritis].
Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)
Ixekizumab and herpes zoster in an erythrodermic patient.
Probable Drug Interaction Between Etanercept and Cyclosporine Resulting in Clinically Unexpected Low Trough Concentrations: First Case Report.
Clinical, Serological and Immunological Characteristics in Greek Patients with Psoriatic Arthritis: The Role of IL-17, IL-23, and Sclerostin.
Axial articular manifestations in primary Sjögren’s syndrome: Association with spondyloarthritis.
A Long Term Study to Demonstrate the Safety and Efficacy of Tildrakizumab in Subjects With Psoriatic Arthritis and Ankylosing Spondylitis or Non-Radiographic Axial Spondyloarthritis.
Impact of guselkumab, an interleukin-23 p19 subunit inhibitor, on enthesitis and dactylitis in patients with moderate to severe psoriatic arthritis: results from a randomised, placebo-controlled, phase II study.
Drug-neutralizing Antibodies against TNF-α blockers as Biomarkers of Therapy Effect Evaluation.
Serum Interleukin-23/17 Levels in Ankylosing Spondylitis Patients Treated with Nonsteroidal Anti-Inflammatory Drugs: A Prospective Cohort Study.
Tumour necrosis factor inhibitors slow radiographic progression in patients with ankylosing spondylitis: 18-year real-world evidence.
Histone H3K27me3 demethylases regulate human Th17 cell development and effector functions by impacting on metabolism.
The roles of ERAP1 and ERAP2 in autoimmunity and cancer immunity: New insights and perspective.
Meloxicam.
Relative risk of end-stage renal disease requiring dialysis in treated ankylosing spondylitis patients compared with individuals without ankylosing spondylitis: A nationwide, population-based, matched-cohort study.
Healthcare-Related Costs Associated with Switching Subcutaneous Tumor Necrosis Factor-α Inhibitor in the Treatment of Inflammatory Arthritis: a Retrospective Study.
Comparative efficacy and safety of secukinumab and ixekizumab in patients with active ankylosing spondylitis.
Bloodstream infection caused by Yersinia enterocolitica in a host with ankylosing spondylitis: a case report and literature review.
Biological therapy safety in chronic inflammatory arthropathy patients.
An update on serum biomarkers to assess axial spondyloarthritis and to guide treatment decision.
Varicella Zoster and Cutaneous Candida Infection in a Patient With Ankylosing Spondylitis Under Treatment With Secukinumab.
Deciding who to treat with biologic disease-modifying antirheumatic drugs in axial spondyloarthritis.
Autoimmune Conditions: Ankylosing Spondylitis.
Risk of Malignancy in Spondyloarthritis: A Systematic Review.
Profiling and Bioinformatics Analysis of Differentially Expressed circRNAs in Spinal Ligament Tissues of Patients with Ankylosing Spondylitis.
Reversible anti-TNFα treatment induced dementia: a case report.
PAPA spectrum disorders.
Prediction of Response to Tumor Necrosis Value-α Blocker Is Suggested by 18F-NaF SUVmax But Not by Quantitative Pharmacokinetic Analysis in Patients With Ankylosing Spondylitis.
Relationship of pain and fatigue with health-related quality of life and work in patients with psoriatic arthritis on TNFi: results of a multi-national real-world study.
Biomechanical properties of common carotid arteries assessed by circumferential two-dimensional strain and beta stiffness index in patients with ankylosing spondylitis.
Combination treatment with secukinumab and dimethyl fumarate in a patient with psoriasis and recent diagnosis of multiple sclerosis.
Treatment Pattern Analysis and Health-care Resource Consumption on Patients with Psoriatic Arthritis or Ankylosing Spondylitis Treated with Biological Drugs in a Northern Italian Region.
Biomarker development for axial spondyloarthritis.
Golimumab improves socio economic and health economic parameters in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
An innovative prone positioning system for advanced deformity and frailty in complex spine surgery.

[Practice guideline for patients with ankylosing spondylitis/spondyloarthritis].
Effect of lipid and edge activator concentration on development of Aceclofenac loaded transfersomes gel for transdermal application: in vitro and ex vivo skin permeation.
Back Pain in Children and Adolescents.
Coronavirus disease 2019 (COVID-19) in a patient with ankylosing spondylitis treated with secukinumab: a case-based review.
Radiologic and Pathological Investigation of Pseudarthrosis in Ankylosing Spondylitis: Distinguishing Between Inflammatory and Traumatic Etiology.
[JAK inhibitors: Perspectives in internal medicine].
Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies.
Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort.
Development of classification criteria for hand osteoarthritis: comparative analyses of persons with and without hand osteoarthritis.
Drug treatment of ankylosing spondylitis and related complications: an overlook review.
Differences between diffuse idiopathic skeletal hyperostosis and spondyloarthritis.
Impact of biologic DMARDs on quality of life: 12-month results of a rheumatic diseases cohort using the Brazilian EQ-5D tariff.
The impact of fatigue on patients with psoriatic arthritis: a multi-center study of the TLAR-network.
Disorders of the Aorta and Aortic Valve in Connective Tissue Diseases.
Surgical treatment of cervical spine fractures in ankylosing spondylitis patients: posterior stabilization using intraoperative CT scanner-based navigation.
COVID-19 in patients with rheumatological diseases treated with anti-TNF.
A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis
Increased Rates of Both Knee and Hip Arthroplasties in Older Patients with Ankylosing Spondylitis.
Does relocation of the apex after osteotomy affect surgical and clinical outcomes in patients with ankylosing spondylitis and thoracolumbar kyphosis?
Disease activity guided stepwise tapering or discontinuation of rhTNFR:Fc, an etanercept biosimilar, in patients with ankylosing spondylitis: a prospective, randomized, open-label, multicentric study.
Management of intraoperative acetabular fracture in primary total hip arthroplasty.
Influence of age on the occurrence of adverse events in rheumatic patients at the onset of biological treatment: data from the BIOBADASER III register.
Fertility and sexuality of women with inflammatory arthritis.
Biologic disease-modifying anti-rheumatic drugs and patient-reported outcomes in axial SpA: a systematic review and a call for action.
A posterior-only approach for ankylosing spondylitis (AS) with thoracolumbar pseudoarthrosis: a clinical retrospective study.
Induction of Sustained Clinical Remission in Early Axial Spondyloarthritis Following Certolizumab Pegol Treatment: 48-Week Outcomes from C-OPTIMISE.
Bone mineral density improves during 2 years of treatment with bisphosphonates in patients with ankylosing spondylitis.
Biologics, spondylitis and COVID-19.
Outcomes and treatment responses, including work productivity, among people with axial spondyloarthritis living in urban and rural areas: a mixed-methods study within a national register.
An updated review of infliximab biosimilar, CT-P13, in the treatment of immune-mediated inflammatory diseases.
Successful treatment of pemphigus foliaceous and ankylosing spondylitis with infliximab and methotrexate: A case report.
Understanding differences between men and women with axial spondyloarthritis.
Olfactory and Gustatory Dysfunction in a COVID-19 Patient with Ankylosing Spondylitis Treated with Etanercept: Case Report.
Use of prescription opioids among patients with rheumatic diseases compared to patients with hypertension in the USA: a retrospective cohort study.
The comparison analysis of clinical and radiological features in SAPHO syndrome.
Pain- and Fatigue-Related Functional and Structural Changes in Ankylosing Spondylitis: An fRMI Study.
Coincident remission of ankylosing spondylitis after autologous stem cell transplantation for multiple myeloma.
StatPearls
StatPearls
StatPearls
Non-Steroidal Anti-Inflammatory Drug Etoricoxib Facilitates the Application of Individualized Exercise Programs in Patients with Ankylosing Spondylitis.
Rheumatologic Disorders and the Nervous System.
Pityriasis Lichenoides Chronica in a Patient With Ankylosing Spondylitis Treated With Etanercept.
Treatment Patterns and Health Care Resource Utilization Among Japanese Patients With Ankylosing Spondylitis: a Hospital Claims Database Analysis.
Forward flexed posture: reliability and determinants of tragus-to-wall measurement.
Lower concentration of vitamin D is associated with lower DAS28 and VAS-pain scores in patients with inflammatory rheumatic diseases treated with infliximab: a pilot study.
Anti-tumour necrosis factor α therapy – Does it increase the risk of thyroid disease or protect against its development?
A Randomized, Double-Blind, Parallel-Group, Phase 1 Clinical Trial Comparing the Pharmacokinetic, Safety, and Immunogenicity of the Biosimilar HS016 and the Originator Adalimumab in Chinese Healthy Male Subjects.
Traditional Chinese Eight Brocade Exercise Prescription for Ankylosing Spondylitis: A Quantitative Synthesis.
Hepatosplenic T-Cell Lymphoma Arising in a Patient Treated With Tumor Necrosis Factor-α Inhibitors for Ankylosing Spondylitis.
Risk for development of inflammatory bowel disease under inhibition of interleukin 17: A systematic review and meta-analysis.
Efficacy of the anti-IL 17 secukinumab in refractory Behçet’s syndrome: A preliminary study.
Gender bias in therapeutic effort: from research to health care.
Reply to: Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis: a commentary.
Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis: a commentary.
Surgical Treatment for Severe Fixed Hyperkyphosis in an Adult Patient Suffering From Ankylosing Spondylitis and Hereditary Hypophosphatemia With Vertebral Osteopetrosis.
Lessons learnt from delayed diagnosis of FGF-23-producing tumour-induced osteomalacia and post-operative hungry bone syndrome.
A case of severe flare reaction observed in HLA B27 associated acute anterior uveitis.
Paradoxical Skin Reaction to Certolizumab, an Overlap of Pyoderma Gangrenosum and Psoriasis in a Young Woman Treated for Ankylosing Spondylitis: Case Report with Literature Review.
Risk of Serious Infection Associated with Agents that Target T-Cell Activation and Interleukin-17 and Interleukin-23 Cytokines.
Predictive value of semi-quantitative index from F-18-fluoride PET/CT for treatment response in patients with ankylosing spondylitis.
Impact of Persistence with Tumor Necrosis Factor Inhibitors on Healthcare Resource Utilization and Costs in Chronic Inflammatory Joint Diseases.
Association of body mass index on disease activity in axial spondyloarthritis: systematic review and meta-analysis.
Back pain, ankylosing spondylitis and social media usage; a descriptive analysis of current activity.
Evaluation of changes in choroidal vascularity during acute anterior uveitis attack in patients with ankylosing spondylitis by using binarization of EDI-optical coherence tomography images.
Early differential diagnosis of ankylosing spondylitis among patients with low back pain in primary care.
Impact of skin, musculoskeletal and psychosocial aspects on quality of life in psoriatic arthritis patients: A cross-sectional study of outpatient clinic patients in the biologic treatment era.
State of the Art Management of Aortic Valve Disease in Ankylosing Spondylitis.
Medication persistence on biological therapies prescribed for the treatment of chronic inflammatory arthropathies: a real-world data study.
One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study.
Efficacy of tofacitinib in reducing pain in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis.
Study of Apremilast to Treat Subjects With Active Ankylosing Spondylitis
Paradoxical plaque psoriasis due to Secukinumab treatment in an ankylosing spondylitis patient.
Peripheral spondyloarthritis: a neglected entity-state of the art.
Preclinical cardiac organ damage during statin treatment in patients with inflammatory joint diseases: the RORA-AS statin intervention study.
Maintenance of clinical remission in early axial spondyloarthritis following certolizumab pegol dose reduction.
Efficacy of needle-knife combined with etanercept treatment regarding disease activity and hip joint function in ankylosing spondylitis patients with hip joint involvement: A randomized controlled study.
Sleep apnea-hypopnea syndrome caused by ankylosing spondylitis: A case report.
Serum homocysteine levels and their association with clinical characteristics of inflammatory arthritis.
Secukinumab Use in Patients with Moderate to Severe Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis in Real-World Setting in Europe: Baseline Data from SERENA Study.
Effect of Dysmetabolisms and Comorbidities on the Efficacy and Safety of Biological Therapy in Chronic Inflammatory Joint Diseases.
Treat-to-target in axial spondyloarthritis: gold standard or fools’ gold?
New onset of psoriasis induced by secukinumab in a patient with ankylosing spondylitis: a case report.
Differences between females and males in axial spondyloarthritis: data from a real-life cross-sectional cohort.
High-Intensity Exercise Improves Fatigue, Sleep, and Mood in Patients With Axial Spondyloarthritis: Secondary Analysis of a Randomized Controlled Trial.
Propensity score matching/reweighting analysis comparing intravenous golimumab to infliximab for ankylosing spondylitis using data from the GO-ALIVE and ASSERT trials.
Association Between Nursing Support Levels and Effectiveness of Golimumab in the Management of Patients with Rheumatologic Diseases.
Membranous nephropathy and thymoma in a patient with ankylosing spondylitis: A case report.
Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept.
Post-Marketing Pooled Safety Analysis for CT-P13 Treatment of Patients with Immune-Mediated Inflammatory Diseases in Observational Cohort Studies.
Ankylosing spondylitis – specific aspects related to surgical treatment of cervical fracture – case report.
Incidence of Uveitis in Secukinumab-treated Patients With Ankylosing Spondylitis: Pooled Data Analysis From Three Phase 3 Studies.
Administration of lower doses of radium-224 to ankylosing spondylitis patients results in no evidence of significant overall detriment.
Treat to Target in Axial Spondyloarthritis: Pros, Cons, and Future Directions.
The Future of Axial Spondyloathritis Treatment.
Axial Spondyloarthritis in the Era of Precision Medicine.
The Patient’s Perspective on the Burden of Disease in Ankylosing Spondylitis.
The use of biologics for uveitis associated with spondyloarthritis.
Real-world evidence of TNF inhibition in axial spondyloarthritis: can we generalise the results from clinical trials?
A 5-year Retrospective Analysis of Drug Survival, Safety, and Effectiveness of the Infliximab Biosimilar CT-P13 in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis.

Drug Levels and Antibodies Against TNF-blockers in Spondyloarthritis and Rheumatoid Arthritis are Associated with the Activity but they do Not Predict it.
Long-Term Effectiveness of Secukinumab in Patients with Axial Spondyloarthritis.
Moxibustion for the treatment of ankylosing spondylitis: a systematic review and meta-analysis.
Profile of common inflammatory markers in treatment-naïve patients with systemic rheumatic diseases.
Educational needs of patients with rheumatic and musculoskeletal diseases attending a large health facility in Austria.
Long-term follow-up after switching from originator infliximab to its biosimilar CT-P13: the weight of nocebo effect.
Study to Evaluate Maintenance of Sustained Remission of axSpA With CZP Compared to Placebo
2018 update of the EULAR recommendations for the role of the nurse in the management of chronic inflammatory arthritis.
Association between C-reactive protein gene variant and treatment efficacy of etanercept in ankylosing spondylitis patients receiving hip arthroplasty.
Golimumab as the First-, Second-, or at Least Third-Line Biologic Agent in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis: Post Hoc Analysis of a Noninterventional Study in Germany.
Influence of therapeutic drugs on different manifestations of renal involvement in 907 Chinese patients with ankylosing spondylitis .
Factors for starting biosimilar TNF inhibitors in patients with rheumatic diseases in the real world.
Eruptive melanocytic nevi during etanercept treatment in an ankylosing spondylitis patient: Case report.
Clinical efficacy and safety of certolizumab pegol in cutaneous symptoms on psoriasis in patients with psoriatic arthritis : a retrospective analysis in real life.
Active ankylosing spondylitis increases blood loss during total hip arthroplasty for a stiff hip joint.
50 Years Ago in The Journal of Pediatrics: Ankylosing Spondylitis with Childhood Onset.
HLA risk alleles and gut microbiome in ankylosing spondylitis and rheumatoid arthritis.
Determination of Use of Alternative Medicine Methods in Patients With Ankylosing Spondylitis.
Early stage Acute B lymphocytic leukemia presenting with symptoms of ankylosing spondylitis (AS): A case report.
Neuropathic component of low back pain in patients with ankylosing spondylitis.
Healthcare resource utilization and costs associated with inflammatory bowel disease among patients with chronic inflammatory diseases: a retrospective cohort study.
Effects of Andersson lesion treatment in ankylosing spondylitis: A medical record review study focused on medium- to long-term outcomes.
Research Progress on Anti-Inflammatory Effects and Mechanisms of Alkaloids from Chinese Medical Herbs.
Indirect comparison of NSAIDs for ankylosing spondylitis: Network meta-analysis of randomized, double-blinded, controlled trials.
Educational needs in people with ankylosing spondylitis and psoriatic arthritis: a cross-sectional study.
Development of eosinophilic fasciitis during treatment with certolizumab pegol for ankylosing spondylitis.
Adalimumab as a successful alternative for the treatment of infliximab-induced sarcoidosis.
Follicular occlusion triad: an isotopic response or adverse effect of rituximab?
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies
What constitutes the fat signal detected by MRI in the spine of patients with ankylosing spondylitis? A prospective study based on biopsies obtained during planned spinal osteotomy to correct hyperkyphosis or spinal stenosis.
The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies.
Incidence of Serious Infections and Design of Utilization and Safety Studies for Biologic and Biosimilar Surveillance.
Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis.
Axial Spondyloarthritis after bariatric surgery: a 7-year retrospective analysis.
New targeted therapies in spondyloarthritis: what are the limits?
Clinical results and surgery tactics of spinal osteotomy for ankylosing spondylitis kyphosis: experience of 428 patients.
Diffuse idiopathic skeletal hyperostosis in a 33-year-old woman with PCOS and metabolic syndrome: a rare scenario.
Injuries to the Rigid Spine: What the Spine Surgeon Wants to Know.
Effects of ustekinumab on spondylitis-associated endpoints in TNFi-naïve active psoriatic arthritis patients with physician-reported spondylitis: pooled results from two phase 3, randomised, controlled trials.
Circulating Retinol-Binding Protein 4 as a Possible Biomarker of Treatment Response for Ankylosing Spondylitis: An Array-Based Comparative Study.
Rapid recurrence of dermatofibrosarcoma protuberans after initiation of adalimumab therapy in a patient with ankylosing spondylitis.
Structural damage and motion rhythm of the spine and hip during trunk lateral bending in ankylosing spondylitis patients with mild to moderate radiographic signs.
Investigation of the effectiveness of aerobic exercise training in individuals with ankylosing spondylitis: randomized controlled study.
Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer’s disease in patients with rheumatoid arthritis and psoriasis.
Added value of biomarkers compared with clinical parameters for the prediction of radiographic spinal progression in axial spondyloarthritis.
Determinants of diagnostic delay in axial spondyloarthritis: an analysis based on linked claims and patient-reported survey data.
Spinal radiographic progression in axial spondyloarthritis and the impact of classification as nonradiographic versus radiographic disease: Data from the Swiss Clinical Quality Management cohort.
The Influence of Pelvic Tilt on the Anteversion Angle of the Acetabular Prosthesis.
Total hip arthroplasty by direct anterior approach in the lateral position for the treatment of ankylosed hips.
Clinical observation of Qushi Xiezhuo formula in reducing monosodium urate crystal deposition in patients with axial spondyloarthritis.
Biologic therapy and spinal radiographic progression in patients with axial spondyloarthritis: A structured literature review.
Tumour necrosis factor inhibitor dose reduction for axial spondyloarthritis: A systematic review and meta-analysis of randomized controlled trials.
Dynamic Variations in Gut Microbiota in Ankylosing Spondylitis Patients Treated with Anti-TNF-α for Six Months.
Risk of neuroinflammatory events in arthritis patients treated with tumour necrosis factor alpha inhibitors: a collaborative population-based cohort study from Denmark and Sweden.
Unmet needs in ankylosing spondylitis patients receiving tumour necrosis factor inhibitor therapy; results from a large multinational real-world study.
Study of Efficacy and Safety of Secukinumab in Patients With Ankylosing Spondylitis
Core stability and balance in patients with ankylosing spondylitis.
The comparative efficacy of supervised- versus home-based exercise programs in patients with ankylosing spondylitis: A meta-analysis.
Eligibility criteria for biologic disease-modifying antirheumatic drugs in axial spondyloarthritis: going beyond BASDAI.
Remission in Axial Spondyloarthritis: Developing a Consensus Definition.
Impact of Ramadan diurnal intermittent fasting on rheumatic diseases.
Secukinumab-induced Raynaud’s phenomenon: first report in the literature.
The IgG galactosylation ratio is higher in spondyloarthritis patients and associated with the MRI score.
Prevalence of ankylosing spondylitis in a Chinese population: a systematic review and meta-analysis.
NOVEL PATIENT POSITIONING APPARATUS FOR RETINAL SURGERY IN A CASE OF SEVERE KYPHOSIS.
The IL-23-IL-17 pathway as a therapeutic target in axial spondyloarthritis.
Factors Affecting Quality of Life and Satisfaction in Patients with Arthritis after Change to a Fixed-Dose Naproxen/Esomeprazole Combination Drug.
Complications of Total Hip Arthroplasty in Patients With Ankylosing Spondylitis.
Vascular involvement in axial spondyloarthropathies.
Patients with axial spondyloarthritis report significant differences between men and women and high impact of the disease: large websurvey analysis.
Neighborhood Deprivation and Risks of Autoimmune Disorders: A National Cohort Study in Sweden.
Association of ankylosing spondylitis with radiographically and clinically diagnosed apical periodontitis: A cross-sectional study.
Low Incidence of Inflammatory Bowel Disease Adverse Events in Adalimumab Clinical Trials Across Nine Different Diseases.
Cardiac Arrhythmias in Autoimmune Diseases.
A Study of Ixekizumab (LY2439821) in Chinese Participants With Radiographic Axial Spondyloarthritis
Circular RNAs hsa_circ_0000479 in peripheral blood mononuclear cells as novel biomarkers for systemic lupus erythematosus.
Elevated faecal calprotectin is linked to worse disease status in axial spondyloarthritis: results from the SPARTAKUS cohort.
Could that back pain be caused by ankylosing spondylitis?
Correlation Between Chronic Pain Acceptance and Clinical Variables in Ankylosing Spondylitis and Its Prediction Role for Biologics Treatment.
Comparison of the Efficacy and Safety of Adalimumab (Humira) and the Adalimumab Biosimilar Candidate (HS016) in Chinese Patients with Active Ankylosing Spondylitis: A Multicenter, Randomized, Double-Blind, Parallel, Phase III Clinical Trial.
Use of antidepressants and benzodiazepine-related hypnotics before and after initiation of TNF-α inhibitors or non-biological systemic treatment in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis.
SKIPPAIN – Speed of Onset of SecuKinumab-Induced Relief From Pain in Patients With AxIal SpoNdyloarthritis
A case of new onset ulcerative colitis following secukinumab treatment.
[Editorial – S3 guidelines for axial spondyloarthritis including Bechterew’s disease and early forms : Update 2019].
[Long version on the S3 guidelines for axial spondyloarthritis including Bechterew’s disease and early forms, Update 2019 : Evidence-based guidelines of the German Society for Rheumatology (DGRh) and participating medical scientific specialist societies and other organizations].
The risk and consequences of vertebral fracture in patients with Ankylosing Spondylitis: a population-based data linkage study.
Mimickers of Hill-Sachs Lesions.
Micro-RNAs in inflammatory arthritis: From physiopathology to diagnosis, prognosis and therapeutic opportunities.
Body Weight as a Determining Factor in the Predominance of Adverse Drug Reactions Induced by Fixed-Dose Adalimumab Injections in Female Patients in a Korean Hospital Setting.
Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar)
Study of Efficacy and Safety of Secukinumab in Patients With Non-radiographic Axial Spondyloarthritis
Comment on “Effects of 1-year anti-TNF-α therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis”.
Enthesitis and its relationship with disease activity, functional status, and quality of life in psoriatic arthritis: a multi-center study.
Enthesitis and its relationship with disease activity, functional status, and quality of life in psoriatic arthritis: a multi-center study.
Efficacy and Safety in the Continued Treatment With a Biosimilar Drug in Patients Receiving Infliximab: A Systematic Review in the Context of Decision-Making From a Latin-American Country.
A Study to Evaluate the Long Term Safety and Efficacy of Bimekizumab in Subjects With Ankylosing Spondylitis
Effect of tumor necrosis factor inhibition on spinal inflammation and spinal ankylosis in SKG mice.
Study to Evaluate the Effect of Filgotinib on Semen Parameters in Adult Males With Active Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, or Non-radiographic Axial Spondyloarthritis
Enthesitis and its relationship with disease activity, functional status, and quality of life in psoriatic arthritis: a multi-center study.
Poor efficacy of TNF inhibitors in non-radiographic axial spondyloarthritis in the absence of objective signs: A bicentric retrospective study.

Efficacy, immunogenicity and cost analysis of a systematic switch from originator infliximab to biosimilar CT-P13 of all patients with inflammatory arthritis from a single center.
High prevalence of sacrococcygeal pilonidal sinus disease in patients with ankylosing spondylitis.
Real-time PCR based HLA-B*27 screening directly in whole blood.
Treatment retention of infliximab and etanercept originators versus their corresponding biosimilars: Nordic collaborative observational study of 2334 biologics naïve patients with spondyloarthritis.
Crowned dens syndrome, yet another rheumatic disease imposter.
Dose reduction of biological therapies for inflammatory rheumatic diseases: what do patients think?
Role of interleukin (IL)-17 in inflammatory and immune disorders (including ankylosing spondylitis): An updated review of the evidence and discussion on potential use of IL-17A blocking agents for the treatment of AS
Management of vaccination in rheumatic disease.
Comparing patient-reported outcomes entered at home versus at hospital, and testing touch screens for initial recruitment to scientific trials in arthritis patients.
‘Isn’t biological treatment something healthy?’ Lay people’s perceptions of medical terms.
Role of Microparticles in the Pathogenesis of Inflammatory Joint Diseases.
Biologics versus Immunomodulators for the Treatment of Ulcerative Colitis: A Review of Comparative Clinical Effectiveness and Cost-Effectiveness
Structural progression rate decreases over time on serial radiography and magnetic resonance imaging of sacroiliac joints and spine in a five-year follow-up study of patients with ankylosing spondylitis treated with tumour necrosis factor inhibitor.
[Mid- and long-term effectiveness of total hip arthroplasty with Ribbed femoral stem prosthesis in 354 cases].
Three Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis.
Factors Predictive of Radiographic Progression in Ankylosing Spondylitis.
Assessing Physical Activity and Sleep in Axial Spondyloarthritis: Measuring the Gap.
Ankylosing spondylitis: etiology, pathogenesis, and treatments.
Treatment Patterns with Disease-Modifying Antirheumatic Drugs in U.S. Veterans with Newly Diagnosed Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis.
Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019.
Determining factors related to poor quality of life in patients with axial spondyloarthritis: results from the British Society for Rheumatology Biologics Register (BSRBR-AS).
Shotgun metagenomics reveals an enrichment of potentially cross-reactive bacterial epitopes in ankylosing spondylitis patients, as well as the effects of TNFi therapy upon microbiome composition.
16 Week Efficacy and 5 Year Long Term Efficacy, Safety and Tolerability of Secukinumab in Patients With Active Ankylosing Spondylitis
A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis
Surgical treatment of a cervical spine fracture in an ankylosing spondylitis patient with severe global spine kyphosis and chin-on-chest deformity.
The case for T2 pedicle subtraction osteotomy in the surgical treatment of rigid cervicothoracic deformity.
Successful treatment in a child with enthesitis-related arthritis involving the sternoclavicular joint: a case report.
Pharmacological management of axial spondyloarthritis in adults.
Osteonecrosis and osteomyelitis of the jaw associated with tumour necrosis factor-alpha (TNF-α) inhibitors: a systematic review.
Current standardized therapeutic approach for uveitis in Japan.
Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn’s Disease
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
Non-steroidal Anti-inflammatory Drugs Are Unlikely to Inhibit Radiographic Progression of Ankylosing Spondylitis: A Systematic Review.
Use of Disease-modifying Antirheumatic Drugs for Inflammatory Arthritis in US Veterans: Effect of Specialty Care and Geographic Distance.
A Systematic Review of Quality Measures for Inflammatory Arthritis.
Safety and Efficacy of Golimumab Administered Intravenously in Adults with Ankylosing Spondylitis: Results through Week 28 of the GO-ALIVE Study.
Challenges and Advances in Targeting Remission in Axial Spondyloarthritis.
Radiographic Progression in Ankylosing Spondylitis: From Prognostication to Disease Modification.
Smoking cessation intervention for reducing disease activity in chronic autoimmune inflammatory joint diseases.
Novel autophagy-associated target proteins may offer promising drug target for treatment of rheumatic diseases such as ankylosing spondylitis (AS)
Complications of spinal osteotomy for thoracolumbar kyphosis secondary to ankylosing spondylitis in 342 patients: incidence and risk factors.
Palmoplantar pustulosis secondary to anti-tumor necrosis factor therapy in a patient with ankylosing spondylitis.
Should isoniazid prophylaxis be prescribed to the patients under tumor necrosis factor-alpha antagonists independent of tuberculin skin test?
Effect of Secukinumab on the Different GRAPPA-OMERACT Core Domains in Psoriatic Arthritis: A Pooled Analysis of 2049 Patients.
Awareness of axial spondyloarthritis among chiropractors and osteopaths: findings from a UK Web-based survey.
Hip resurfacing arthroplasty for patients with inflammatory arthritis: a systematic review.
Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis.
Venous involvement in inflammatory disorders.
Study of Efficacy and Safety of Secukinumab in Patients With Non-radiographic Axial Spondyloarthritis
Surgical outcomes of traumatic cervical fractures in patients with ankylosing spondylitis.
A cross-sectional study on factors associated with poor work outcomes in patients with axial spondyloarthritis in Singapore.
Ankylosing spondylitis causes high burden to patients and the healthcare system: results from a German claims database analysis.
Genotypes, phenotypes and treatment with immunomodulators in the rheumatic diseases.
No deterioration in health-related quality of life in patients with axial spondyloarthritis followed for 5 years in ordinary outpatient clinics in the biological treatment era.
Effects of Pregnancy and Delivery Methods on Change in Ankylosing Spondylitis Treatment Using the Korean Health Insurance Review and Assessment Service Claims Database.
Physical therapists’ ability to distinguish between inflammatory and noninflammatory arthritis and to appropriately refer to rheumatology.
Swiss ball exercises improve muscle strength and walking performance in ankylosing spondylitis: a randomized controlled trial.